NCT04935528View on ClinicalTrials.gov

Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center

NACompletedINTERVENTIONAL
Enrollment

539

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

January 26, 2022

Study Completion Date

January 26, 2022

Conditions
Cancer
Interventions
BIOLOGICAL

serology and ELISPOT test

27 mL blood sample to study the humoral and the cellular immune response

BIOLOGICAL

serology

7 mL blood sample to study the humoral response

Trial Locations (1)

21079

Centre Georges Francois Leclerc, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER